Correlation Between Esperion Therapeutics and Iteos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Esperion Therapeutics and Iteos Therapeutics, you can compare the effects of market volatilities on Esperion Therapeutics and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Iteos Therapeutics.

Diversification Opportunities for Esperion Therapeutics and Iteos Therapeutics

0.7

Correlation Coefficient

Esperion Therapeutics  Iteos Therapeutics

Poor diversification

The 3 months correlation between Esperion and Iteos is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and Iteos Therapeutics

Given the investment horizon of 90 days Esperion Therapeutics is expected to under-perform the Iteos Therapeutics. In addition to that, Esperion Therapeutics is 1.32 times more volatile than Iteos Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.07 per unit of volatility. If you would invest  729.00  in Iteos Therapeutics on December 29, 2024 and sell it today you would lose (97.00) from holding Iteos Therapeutics or give up 13.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Esperion Therapeutics  vs.  Iteos Therapeutics

Esperion Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Esperion Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Iteos Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Esperion Therapeutics and Iteos Therapeutics

The main advantage of trading using opposite Esperion Therapeutics and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.

The idea behind Esperion Therapeutics and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.